NLRP3 and atrial fibrillation: Conversely, a study of salt-sensitive Dahl rats with heart failure with preserved ejection fraction (HFpEF) demonstrated that inhibition of the NLRP3 inflammasome with dapansutrile reduces atrial fibrillation (AF) by decreasing atrial inflammation and improving calcium handling [106].